5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile, 97%, 1g

5-Bromo-2-hydroxyisonicotinic acid, 95.0%, 5g

Pyridine-3-boronic acid, 97.0%, 10g

1-Methyl-4-(2-methyl-4-nitrophenyl)piperazine, 95.0%, 5g

5,8,11-Trioxa-2-azatridecanoic acid, 13-hydroxy-, 9H-fluoren-9-ylmethylester, 97%, 100mg

2-(4-FLUOROPHENYL)-6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZIN-4(5H)-ONE, 95.0%, 500mg

(2E)-1-(3,4-dichlorophenyl)-3-(5-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

7-(Diethylamino)coumarin-3-carboxylic acid, 95.0%, 100g

tert-Butyl N-[1-(4-bromophenyl)cyclopropyl]carbamate, 95.0%, 5g

3-BENZYLOXY-6-METHYL-PYRROLO[3,4-B]PYRIDINE-5,7-DIONE, 95.0%, 100mg

2-Amino-4-(trifluoromethyl)pyrimidine-5-carbaldehyde, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-1, 30 m, 0,32 mm, 0,50 µm, 1 pièce(s)

3-(N-(tert-Butyldimethylsilyl)-S-methylsulfonimidoyl)-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate, 100mg